Similar articles for PMID: 27213372

Year	Number of Results
1954	1
2003	1
2006	1
2008	1
2009	1
2011	1
2012	1
2013	4
2014	4
2015	27
2016	22
2017	4
2024	0

1

Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types.

Scognamiglio G, De Chiara A, Di Bonito M, Tatangelo F, Losito NS, Anniciello A, De Cecio R, D'Alterio C, Scala S, Cantile M, Botti G. Scognamiglio G, et al. Int J Mol Sci. 2016 May 21;17(5):790. doi: 10.3390/ijms17050790. Int J Mol Sci. 2016. PMID: 27213372 Free PMC article.

2

Quantitative and qualitative characterization of Two PD-L1 clones: SP263 and E1L3N.

Smith J, Robida MD, Acosta K, Vennapusa B, Mistry A, Martin G, Yates A, Hnatyszyn HJ. Smith J, et al. Diagn Pathol. 2016 May 18;11(1):44. doi: 10.1186/s13000-016-0494-2. Diagn Pathol. 2016. PMID: 27189072 Free PMC article.

3

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer.

McLaughlin J, Han G, Schalper KA, Carvajal-Hausdorf D, Pelekanou V, Rehman J, Velcheti V, Herbst R, LoRusso P, Rimm DL. McLaughlin J, et al. JAMA Oncol. 2016 Jan;2(1):46-54. doi: 10.1001/jamaoncol.2015.3638. JAMA Oncol. 2016. PMID: 26562159 Free PMC article.

4

An Immunohistochemical Analysis of PD-L1 Protein Expression in Surgically Resected Small Cell Lung Cancer Using Different Antibodies and Criteria.

Takada K, Toyokawa G, Okamoto T, Akamine T, Takamori S, Katsura M, Fujishita T, Shoji F, Oda Y, Maehara Y. Takada K, et al. Anticancer Res. 2016 Jul;36(7):3409-12. Anticancer Res. 2016. PMID: 27354600

5

Programmed death ligand-1 expression is associated with poor disease free survival in salivary gland carcinomas.

Mukaigawa T, Hayashi R, Hashimoto K, Ugumori T, Hato N, Fujii S. Mukaigawa T, et al. J Surg Oncol. 2016 Jul;114(1):36-43. doi: 10.1002/jso.24266. Epub 2016 Apr 25. J Surg Oncol. 2016. PMID: 27111278

6

Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma.

Katsuya Y, Fujita Y, Horinouchi H, Ohe Y, Watanabe S, Tsuta K. Katsuya Y, et al. Lung Cancer. 2015 May;88(2):154-9. doi: 10.1016/j.lungcan.2015.03.003. Epub 2015 Mar 10. Lung Cancer. 2015. PMID: 25799277

7

Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva.

Howitt BE, Sun HH, Roemer MG, Kelley A, Chapuy B, Aviki E, Pak C, Connelly C, Gjini E, Shi Y, Lee L, Viswanathan A, Horowitz N, Neuberg D, Crum CP, Lindeman NL, Kuo F, Ligon AH, Freeman GJ, Hodi FS, Shipp MA, Rodig SJ. Howitt BE, et al. JAMA Oncol. 2016 Apr;2(4):518-22. doi: 10.1001/jamaoncol.2015.6326. JAMA Oncol. 2016. PMID: 26913631

8

Validated programmed cell death ligand 1 immunohistochemistry assays (E1L3N and SP142) reveal similar immune cell staining patterns in melanoma when using the same sensitive detection system.

Schats KA, Van Vré EA, De Schepper S, Boeckx C, Schrijvers DM, Waelput W, Fransen E, Vanden Bempt I, Neyns B, De Meester I, Kockx MM. Schats KA, et al. Histopathology. 2017 Jan;70(2):253-263. doi: 10.1111/his.13056. Epub 2016 Oct 10. Histopathology. 2017. PMID: 27496355

9

Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153.

Baban B, Liu JY, Qin X, Weintraub NL, Mozaffari MS. Baban B, et al. PLoS One. 2015 Apr 22;10(4):e0124059. doi: 10.1371/journal.pone.0124059. eCollection 2015. PLoS One. 2015. PMID: 25902191 Free PMC article.

10

Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas.

Zeng J, Zhang XK, Chen HD, Zhong ZH, Wu QL, Lin SX. Zeng J, et al. Oncotarget. 2016 Feb 23;7(8):8944-55. doi: 10.18632/oncotarget.6884. Oncotarget. 2016. PMID: 26771840 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

60 results

Results by year